Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children

Journal of Infectious Diseases

Volumn 208, Issue 8, 2013, Pages 1320-1324

  Ng, Sophia ^a   Fang, Vicky J ^a   Ip, Dennis K M ^a   Chan, Kwok Hung ^a   Leung, Gabriel M ^a   Peiris, J S Malik ^a   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

antibody; children; immunity; influenza; vaccine

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; PLACEBO; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION; HUMAN; INFECTION PREVENTION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEASONAL INFLUENZA; VIRUS STRAIN;

ANTIBODY; CHILDREN; IMMUNITY; INFLUENZA; VACCINE;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PROPORTIONAL HAZARDS MODELS;

EID: 84885064242     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit372     Document Type: Article

References (15)

1. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972; 70:767-77.
2. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: Development and application of a Bayesian random-effects model. BMC Med Res Methodol 2010; 10:18.
3. Cox RJ. Correlates of protection to influenza virus, where do we go from here? Hum Vaccin Immunother 2013; 9:405-8.
4. Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000; 181:1133-7.
5. Fox JP, Cooney MK, Hall CE, Foy HM. Influenza virus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982; 116:228-42.
6. Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011; 30:1081-5.
7. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: A randomized controlled trial. Clin Infect Dis 2012; 55:695-702.
8. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-84.
9. National Institute for Medical Research. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Southern Hemisphere. 2010.
10. Boucher DW, Contreras G, Furesz J. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine. Can Med Assoc J 1979; 120:799-802, 31.
11. Rastogi S, Gross PA, Bonelli J, et al. Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol 1995; 2:120-1.
12. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51:1370-9.
13. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: Effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203:1309-15.
14. Cauchemez S, Horby P, Fox A, et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 2012; 8:e1003061.
15. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination- inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis 2011; 204:1879-85.